Viewpoints

April 02, 2019

More work needed to advance drug design and development effectively.

April 01, 2019

Uncertainty remains around the UK’s departure from the EU, potentially causing irreparable damage to the bio/pharma sector.

March 02, 2019

Do patients get what they pay for when they demand cheaper drugs?

March 02, 2019

As drug pricing comes under the microscope internationally, it appears that collaboration with all stakeholders is key to tackling the issue.

February 02, 2019

Biosimilars, pricing strategies, and technology will influence growth in spending on drugs.

February 02, 2019

Political instability is causing uncertainty in Europe and wreaking havoc with US regulatory timeframes.

January 18, 2019

The new year has started with a bang in terms of mergers and acquisitions.

January 03, 2019

Drug pricing and reimbursement concerns will continue to hinder industry growth in 2019, according to data and analytics company GlobalData.

January 02, 2019

Pricing pressures, investment volatility, and government disfunction greet Pharma in 2019.

December 02, 2018

Bio/pharma companies cannot spell success without solving all elements of quality programs.